OKUTURLAR, Y. Et Al. 2018. Serum paraoxonase and arylesterase can be useful markers to predict neoadjuvant chemotherapy requirement in patients with breast cancer. JOURNAL OF CANCER RESEARCH AND THERAPEUTICS , vol.14 .

OKUTURLAR, Y., Gunaldi, M., Kocoglu, H., Hursitoglu, M., GEDİKBAŞI, A., Acarer, D., ... Harmankaya, O.(2018). Serum paraoxonase and arylesterase can be useful markers to predict neoadjuvant chemotherapy requirement in patients with breast cancer. JOURNAL OF CANCER RESEARCH AND THERAPEUTICS , vol.14.

OKUTURLAR, YILDIZ Et Al. "Serum paraoxonase and arylesterase can be useful markers to predict neoadjuvant chemotherapy requirement in patients with breast cancer," JOURNAL OF CANCER RESEARCH AND THERAPEUTICS , vol.14, 2018

OKUTURLAR, YILDIZ Et Al. "Serum paraoxonase and arylesterase can be useful markers to predict neoadjuvant chemotherapy requirement in patients with breast cancer." JOURNAL OF CANCER RESEARCH AND THERAPEUTICS , vol.14, 2018

OKUTURLAR, Y. Et Al. (2018) . "Serum paraoxonase and arylesterase can be useful markers to predict neoadjuvant chemotherapy requirement in patients with breast cancer." JOURNAL OF CANCER RESEARCH AND THERAPEUTICS , vol.14.

@article{article, author={YILDIZ OKUTURLAR Et Al. }, title={Serum paraoxonase and arylesterase can be useful markers to predict neoadjuvant chemotherapy requirement in patients with breast cancer}, journal={JOURNAL OF CANCER RESEARCH AND THERAPEUTICS}, year=2018}